Home
About Us
Technology
News
To Order
Contact
Home
About Us
Technology
News
To Order
Contact
•
Dwebb
•
News
•
0
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products
0
Shares
Previous Post
Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements
Next Post
Kelyniam Global Releases 2nd Quarter 2023 Financials
Related Posts
•
December 16, 2024
•
Dwebb
•
News
•
0
Kelyniam Global, Inc. Announces Private Investment to Public Entity (“PIPE”) Closure of Securities Offering
•
November 11, 2024
•
Dwebb
•
News
•
0
Kelyniam Global Releases Q3 Financials | Strong Performance Continues
•
May 14, 2024
•
Dwebb
•
News
•
0
Kelyniam Shows Record Growth in Q1 Financials
